Rating History for Sanofi (SNY) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/1/2026 | Sarita Kapila | Downgrade | Equalweight (Overweight) |
52.00 (55.00) |
46.58 (41.71) |
-10.46% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/1/2026 | Sarita Kapila | Downgrade | Equalweight (Overweight) |
52.00 (55.00) |
46.58 (41.71) |
-10.46% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||